Age-related macular degeneration: a perspective on genetic studies.

Age-related macular degeneration: a perspective on genetic studies.

AIM: Age-related macular degeneration (AMD) is a common macular disease in the developed world and recent studies have shown that specific genes may be associated with it and may contribute to a higher risk of developing AMD. OBJECTIVE: Our objective was to review systematically recent publications...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Patel, N, Adewoyin, T, Chong, N
Natura:	Journal article
Lingua:	English
Pubblicazione:	2008

Documenti analoghi

Pulsatile ocular blood flow in asymmetric age-related macular degeneration.
di: Sandhu, R, et al.
Pubblicazione: (2007)

Computerized model of cost-utility analysis for treatment of age-related macular degeneration.
di: Fletcher, E, et al.
Pubblicazione: (2008)

Estimation of systemic complement C3 activity in age-related macular degeneration.
di: Sivaprasad, S, et al.
Pubblicazione: (2007)

The complement system and age-related macular degeneration.
di: Sivaprasad, S, et al.
Pubblicazione: (2006)

Genetic Insights into Age-Related Macular Degeneration
di: Bhumika, et al.
Pubblicazione: (2024-07-01)

Genetic polymorphisms associated with Age-related macular degeneration
di: Zulvikar Syambani Ulhaq
Pubblicazione: (2020-02-01)

Genetic Risk in Families with Age-Related Macular Degeneration
di: Anita de Breuk, MD, et al.
Pubblicazione: (2021-12-01)

Identification of anti-retinal antibodies in patients with age-related macular degeneration.
di: Morohoshi, K, et al.
Pubblicazione: (2012)

Serum elastin-derived peptides in age-related macular degeneration.
di: Sivaprasad, S, et al.
Pubblicazione: (2005)

A pilot study on the combination treatment of reduced-fluence photodynamic therapy, intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for neovascular age-related macular degeneration.
di: Sivaprasad, S, et al.
Pubblicazione: (2011)

Radiotherapy for neovascular age-related macular degeneration.
di: Evans, JR, et al.
Pubblicazione: (2010)

Drusen classification in bilateral drusen and fellow eye of exudative age-related macular degeneration.
di: Hamada, S, et al.
Pubblicazione: (2006)

Should avastin be used to treat age-related macular degeneration in the NHS?--No.
di: Chong, N
Pubblicazione: (2009)

Age-related macular degeneration
di: Querques G, et al.
Pubblicazione: (2011-05-01)

Age-related macular degeneration
di: Wanjiku Mathenge
Pubblicazione: (2014-12-01)

Metabolomics and Age-Related Macular Degeneration
di: Connor N. Brown, et al.
Pubblicazione: (2018-12-01)

A Pattern of Age-related Macular Degeneration
di: Suprada Pokhrel, et al.
Pubblicazione: (2009-07-01)

Genetic factors associated with the development of age-related macular degeneration
di: Olga Sergejeva, et al.
Pubblicazione: (2016-01-01)

Genetic risk factors and age-related macular degeneration (AMD)
di: Maryam Mousavi, et al.
Pubblicazione: (2013-10-01)

Update on the role of genetics in the onset of age-related macular degeneration
di: Francis PJ, et al.
Pubblicazione: (2011-08-01)

Macular thickness varies with age-related macular degeneration genetic risk variants in the UK Biobank cohort
di: Rebecca A. Kaye, et al.
Pubblicazione: (2021-12-01)

Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization.
di: Morohoshi, K, et al.
Pubblicazione: (2012)

THE PROGNOSTIC VALUE OF PHARMACOLOGICAL AND GENETIC TESTING IN MEDICAL THERAPY OF AGE-RELATED MACULAR DEGENERATION
di: N. A. Bakunina, et al.
Pubblicazione: (2018-10-01)

Stem cells for age-related macular degeneration
di: L.K. Moshetova, et al.
Pubblicazione: (2019-09-01)

Characterizing Macular Neovascularization in Myopic Macular Degeneration and Age-Related Macular Degeneration Using Swept Source OCTA
di: Sayah DN, et al.
Pubblicazione: (2023-12-01)

Genetics and Age-Related Macular Degeneration: A Practical Review for Clinicians
di: Julia Nguyen, et al.
Pubblicazione: (2024-02-01)

Genetics and age-related macular degeneration: a practical review for the clinician
di: Schwartz SG, et al.
Pubblicazione: (2016-07-01)

Optical coherence tomography in neovascular age-related macular degeneration
di: Chong, V
Pubblicazione: (2012)

Pharmacogenetics and Age-Related Macular Degeneration
di: Stephen G. Schwartz, et al.
Pubblicazione: (2011-01-01)

Choriocapillaris in Age-Related Macular Degeneration
di: Giovanni Neri, et al.
Pubblicazione: (2024-08-01)

Nanotechnology for Age-Related Macular Degeneration
di: Bo Yang, et al.
Pubblicazione: (2021-11-01)

Age-Related Macular or Retinal Degeneration?
di: Michalina Gałuszka, et al.
Pubblicazione: (2023-05-01)

Pharmacotherapy for Age-Related Macular Degeneration
di: Hamid Ahmadieh
Pubblicazione: (2008-12-01)

Neuroprotection for Age-Related Macular Degeneration
di: Jonathan B. Lin, MD, PhD, et al.
Pubblicazione: (2022-12-01)

Age-related macular degeneration and the aging eye
di: Rita Ehrlich, et al.
Pubblicazione: (2008-09-01)

Targeting the Complement Cascade for Treatment of Dry Age-Related Macular Degeneration
di: Prem N. Patel, et al.
Pubblicazione: (2022-08-01)

Systemic complement activation in age-related macular degeneration.
di: Hendrik P N Scholl, et al.
Pubblicazione: (2008-07-01)

Importance of genetic polymorphisms in the response to age-related macular degeneration treatment
di: Carlos Eduardo dos Reis Veloso, et al.
Pubblicazione: (2012-06-01)

Epistatic interactions of genetic loci associated with age-related macular degeneration
di: Christina Kiel, et al.
Pubblicazione: (2021-06-01)

Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages.
di: Tina Schick, et al.
Pubblicazione: (2016-01-01)